Pegatron Combination Therapy
Pegatron Combination Therapy - Basic Information
- GN:Peginterferon alfa-2b
- Ribavirin
- Con: Hepatitis c virus (hcv)
- Cla: information not available
Pegatron Combination Therapy - Indication of :
PEGATRON Combination Therapy is used for the treatment of chronic Hepatitis C (a viral infection of the liver) in patients (18 years or older) who have compensated liver disease and have not previously received Interferon alfa treatment.Pegatron Combination Therapy consists of two products, an injection called Peg-Intron and capsules called Rebetol.The active ingredient in Peg-Intron is peginterferon alfa-2b. Peginterferon alfa-2b belongs to a group of medicines called interferons. Interferons are a family of naturally occurring small protein molecules. They are produced and secreted by cells in response to viral infections or various synthetic and biological inducers. Interferons modify the response of the bodys immune system to help fight infections and severe diseases.Rebetol capsules contain an antiviral agent called ribavirin. Rebetol (ribavirin) capsules are not effective when used alone to treat chronic hepatitis C and must only be used in combination with PEG-Intron injections.The combination of Rebetol capsules and Peg-Intron Injection makes the treatment of hepatitis C more effective.For more health information on Pegatron Combination Therapy visit your local doctor.
Pegatron Combination Therapy - Details
- Indication of pegatron combination therapy
- Action of pegatron combination therapy
- Dose advice of pegatron combination therapy
- Schedule of pegatron combination therapy
- Common side effects of pegatron combination therapy
- Uncommon side effects of pegatron combination therapy
- Diseases treated by pegatron combination therapy
GN: Peginterferon alfa-2b
Con: Hepatitis C virus (HCV)